- Home
- RAYA vs MDCX Comparison
RAYA vs MDCX Comparison
Compare RAYA & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- MDCX
- Stock Information
- Founded
- RAYA 2019
- MDCX 2008
- Country
- RAYA China
- MDCX Canada
- Employees
- RAYA N/A
- MDCX N/A
- Industry
- RAYA Metal Fabrications
- MDCX
- Sector
- RAYA Consumer Discretionary
- MDCX
- Exchange
- RAYA Nasdaq
- MDCX Nasdaq
- Market Cap
- RAYA 89.2M
- MDCX 44.0M
- IPO Year
- RAYA 2022
- MDCX N/A
- Fundamental
- Price
- RAYA $2.60
- MDCX $3.38
- Analyst Decision
- RAYA
- MDCX Strong Buy
- Analyst Count
- RAYA 0
- MDCX 2
- Target Price
- RAYA N/A
- MDCX $23.50
- AVG Volume (30 Days)
- RAYA 186.9K
- MDCX 286.2K
- Earning Date
- RAYA 01-01-0001
- MDCX 08-22-2025
- Dividend Yield
- RAYA N/A
- MDCX N/A
- EPS Growth
- RAYA N/A
- MDCX N/A
- EPS
- RAYA N/A
- MDCX N/A
- Revenue
- RAYA $30,300,360.00
- MDCX N/A
- Revenue This Year
- RAYA $20.95
- MDCX N/A
- Revenue Next Year
- RAYA N/A
- MDCX N/A
- P/E Ratio
- RAYA N/A
- MDCX N/A
- Revenue Growth
- RAYA 49.10
- MDCX N/A
- 52 Week Low
- RAYA $0.56
- MDCX $1.80
- 52 Week High
- RAYA $2.88
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- RAYA 68.12
- MDCX N/A
- Support Level
- RAYA $1.94
- MDCX N/A
- Resistance Level
- RAYA $2.88
- MDCX N/A
- Average True Range (ATR)
- RAYA 0.32
- MDCX 0.00
- MACD
- RAYA 0.03
- MDCX 0.00
- Stochastic Oscillator
- RAYA 77.05
- MDCX 0.00
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.